BioNxt Solutions Inc. (OTCMKTS:BNXTF) Short Interest Up 6.8% in December

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the target of a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 4,700 shares, a growth of 6.8% from the December 15th total of 4,400 shares. Based on an average daily volume of 6,700 shares, the short-interest ratio is currently 0.7 days.

BioNxt Solutions Stock Performance

Shares of OTCMKTS:BNXTF opened at $0.25 on Friday. BioNxt Solutions has a twelve month low of $0.11 and a twelve month high of $0.53. The company’s 50 day moving average is $0.22 and its 200 day moving average is $0.20.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.